The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
- Status
- UNKNOWN
- Phase
- PHASE1
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MEDI5752 in Japanese Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 1 Trial of KH617
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of ASP2074 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
- Status
- RECRUITING
- Phase
- PHASE1
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2